We are live on
!
Find out more
PM
Pembroke Management Portfolio holdings
AUM
$774M
1-Year Est. Return
40.73%
This Fund
S&P 500
This Quarter
Est. Return
+21.23%
1 Year Est. Return
+40.73%
3 Year Est. Return
+94.47%
5 Year Est. Return
+109.57%
10 Year Est. Return
+778.41%
AUM
$774M
AUM Growth
+$82.3M
(+12%)
Cap. Flow
-$24.7M
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
42.82%
Holding
112
New
15
Increased
22
Reduced
59
Closed
12
Avg Time Held
7.8
quarters
Top 10 Avg Time Held
2.9
quarters
Top 20 Avg Time Held
6.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VSE Corp
VSEC
|
+$19.2M |
| 2 |
Ollie's Bargain Outlet
OLLI
|
+$15.6M |
| 3 |
Ligand Pharmaceuticals
LGND
|
+$9.49M |
| 4 |
Timken Company
TKR
|
+$8.93M |
| 5 |
Saia
SAIA
|
+$5.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$19.5M |
| 2 |
MDA Space Ltd
MDA
|
+$16.9M |
| 3 |
Aaon
AAON
|
+$15.6M |
| 4 |
Workiva
WK
|
+$13.4M |
| 5 |
Core & Main
CNM
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 37.18% |
| 2 | Technology | 17.33% |
| 3 | Consumer Discretionary | 14.77% |
| 4 | Financials | 10.07% |
| 5 | Healthcare | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Boston Scientific
BSX
$63.5B
| – | – |
-3,736
| Closed | -$234K | – |
|
102
Chewy
CHWY
$7.84B
| – | – |
-160,327
| Closed | -$4.33M | – |
|
103
CoStar Group
CSGP
$11.8B
| – | – |
-5,241
| Closed | -$211K | – |
|
104
Casella Waste Systems
CWST
$5.42B
| – | – |
-17,073
| Closed | -$1.35M | – |
|
105
CGI
GIB
$14.6B
| – | – |
-14,220
| Closed | -$1.04M | – |
|
106
LCI Industries
LCII
$1.92B
| – | – |
-42,026
| Closed | -$5.17M | – |
|
107
Q2 Holdings
QTWO
$3.69B
| – | – |
-91,885
| Closed | -$4.35M | – |
|
108
Stantec
STN
$7.51B
| – | – |
-6,933
| Closed | -$599K | – |
|
109
Stevanato
STVN
$5.25B
| – | – |
-150,818
| Closed | -$2.07M | – |
|
|
110
Bio-Techne
TECH
$11.4B
| – | – |
-372,325
| Closed | -$19.5M | – |
|
111
Veeva Systems
VEEV
$47.9B
| – | – |
-1,218
| Closed | -$214K | – |
|
|
112
Workiva
WK
$3.97B
| – | – |
-224,900
| Closed | -$13.4M | – |
|
Similar funds
CIA
CL
HI
GCM
CI
AF
HI
TCA
Pembroke Management's Q2 2026 Portfolio in Review
As of Q2 2026, Pembroke Management held 112 positions worth $774M, up 12% from $691M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Pembroke Management withdrew a net $24.7M in Q2 2026, closing 12 positions and reducing 59 holdings. Its most notable exit was Bio-Techne, an estimated $19.5M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 37% of assets, down from 38% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Pembroke Management opened a new position in Ligand Pharmaceuticals worth $12.7M.
- Pembroke Management's largest Q2 2026 buy was Ligand Pharmaceuticals: 40,277 shares worth $12.7M.
- Pembroke Management added most to VSE Corp in Q2 2026, an estimated $19.2M increase.
- Pembroke Management's biggest Q2 2026 reduction was MDA Space Ltd, cutting an estimated $16.9M.
- Pembroke Management fully exited Bio-Techne in Q2 2026, selling an estimated $19.5M.
- Pembroke Management's ten largest holdings make up 43% of its $774M portfolio in Q2 2026.
- Pembroke Management opened 15 new positions and closed 12 in Q2 2026.
- Pembroke Management's portfolio value rose 12% quarter-over-quarter to $774M.
Based on Pembroke Management's 13F filing for Q2 2026, filed 22 Jul 2026.